科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/04/12 | 6,230 | 6,260 | 6,180 | 6,260 | -70 | -1.1% | 200,400 |
2017/04/11 | 6,310 | 6,340 | 6,270 | 6,330 | ±0 | ±0% | 183,500 |
2017/04/10 | 6,460 | 6,480 | 6,300 | 6,330 | -150 | -2.3% | 231,900 |
2017/04/07 | 6,450 | 6,490 | 6,360 | 6,480 | +130 | +2% | 208,100 |
2017/04/06 | 6,430 | 6,450 | 6,310 | 6,350 | -110 | -1.7% | 218,400 |
2017/04/05 | 6,400 | 6,460 | 6,380 | 6,460 | +80 | +1.3% | 143,500 |
2017/04/04 | 6,380 | 6,460 | 6,350 | 6,380 | -20 | -0.3% | 258,100 |
2017/04/03 | 6,300 | 6,430 | 6,290 | 6,400 | +110 | +1.7% | 182,700 |
2017/03/31 | 6,400 | 6,460 | 6,290 | 6,290 | -100 | -1.6% | 208,500 |
2017/03/30 | 6,540 | 6,540 | 6,390 | 6,390 | -140 | -2.1% | 171,400 |
2017/03/29 | 6,610 | 6,640 | 6,500 | 6,530 | -110 | -1.7% | 191,200 |
2017/03/28 | 6,550 | 6,660 | 6,540 | 6,640 | +130 | +2% | 185,900 |
2017/03/27 | 6,530 | 6,560 | 6,470 | 6,510 | -40 | -0.6% | 107,500 |
2017/03/24 | 6,460 | 6,570 | 6,430 | 6,550 | +100 | +1.6% | 141,700 |
2017/03/23 | 6,380 | 6,450 | 6,320 | 6,450 | +80 | +1.3% | 157,700 |
2017/03/22 | 6,380 | 6,420 | 6,350 | 6,370 | -60 | -0.9% | 157,900 |
2017/03/21 | 6,410 | 6,450 | 6,400 | 6,430 | +20 | +0.3% | 120,900 |
2017/03/17 | 6,350 | 6,420 | 6,330 | 6,410 | ±0 | ±0% | 169,100 |
2017/03/16 | 6,330 | 6,420 | 6,320 | 6,410 | +60 | +0.9% | 165,000 |
2017/03/15 | 6,310 | 6,370 | 6,280 | 6,350 | +20 | +0.3% | 117,500 |
2017/03/14 | 6,300 | 6,340 | 6,250 | 6,330 | +30 | +0.5% | 125,700 |
2017/03/13 | 6,290 | 6,310 | 6,260 | 6,300 | +70 | +1.1% | 126,200 |
2017/03/10 | 6,190 | 6,250 | 6,180 | 6,230 | +80 | +1.3% | 207,300 |
2017/03/09 | 6,140 | 6,170 | 6,090 | 6,150 | +60 | +1% | 154,400 |
2017/03/08 | 6,150 | 6,170 | 6,090 | 6,090 | -70 | -1.1% | 183,200 |
2017/03/07 | 6,130 | 6,170 | 6,100 | 6,160 | +30 | +0.5% | 127,800 |
2017/03/06 | 6,100 | 6,160 | 6,090 | 6,130 | ±0 | ±0% | 181,600 |
2017/03/03 | 6,130 | 6,160 | 6,100 | 6,130 | -10 | -0.2% | 166,200 |
2017/03/02 | 6,150 | 6,160 | 6,120 | 6,140 | +50 | +0.8% | 160,400 |
2017/03/01 | 6,020 | 6,120 | 6,020 | 6,090 | +50 | +0.8% | 165,700 |
2017/02/28 | 6,080 | 6,130 | 6,040 | 6,040 | +20 | +0.3% | 235,000 |
2017/02/27 | 5,970 | 6,050 | 5,960 | 6,020 | +10 | +0.2% | 191,200 |
2017/02/24 | 5,940 | 6,040 | 5,930 | 6,010 | +50 | +0.8% | 166,900 |
2017/02/23 | 5,920 | 5,970 | 5,910 | 5,960 | +40 | +0.7% | 115,200 |
2017/02/22 | 5,910 | 5,920 | 5,840 | 5,920 | +10 | +0.2% | 114,500 |
2017/02/21 | 5,830 | 5,910 | 5,820 | 5,910 | +20 | +0.3% | 128,100 |
2017/02/20 | 5,830 | 5,890 | 5,790 | 5,890 | -10 | -0.2% | 110,000 |
2017/02/17 | 5,860 | 5,920 | 5,820 | 5,900 | -20 | -0.3% | 151,300 |
2017/02/16 | 5,910 | 5,940 | 5,870 | 5,920 | +50 | +0.9% | 210,900 |
2017/02/15 | 5,830 | 5,870 | 5,790 | 5,870 | +110 | +1.9% | 297,800 |
2017/02/14 | 5,770 | 5,800 | 5,750 | 5,760 | +60 | +1.1% | 274,600 |
2017/02/13 | 5,670 | 5,730 | 5,660 | 5,700 | +60 | +1.1% | 170,700 |
2017/02/10 | 5,660 | 5,680 | 5,600 | 5,640 | +80 | +1.4% | 205,500 |
2017/02/09 | 5,490 | 5,560 | 5,480 | 5,560 | +50 | +0.9% | 273,400 |
2017/02/08 | 5,440 | 5,510 | 5,440 | 5,510 | +40 | +0.7% | 261,200 |
2017/02/07 | 5,560 | 5,570 | 5,410 | 5,470 | -160 | -2.8% | 394,000 |
2017/02/06 | 5,760 | 5,760 | 5,580 | 5,630 | -110 | -1.9% | 322,300 |
2017/02/03 | 5,710 | 5,760 | 5,700 | 5,740 | +30 | +0.5% | 176,200 |
2017/02/02 | 5,770 | 5,780 | 5,700 | 5,710 | -20 | -0.3% | 111,400 |
2017/02/01 | 5,700 | 5,770 | 5,690 | 5,730 | +10 | +0.2% | 146,600 |
2001~
2050
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム